BCAX   $19.41  1.52% Market Open

Bicara Therapeutics Inc

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 3
Target Price Mean 42
Mean unverified/preliminary 42 / 42
Target Price Low / High 36 / 47
Median / STD DEV 42 / 5.51
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None ActivelyBuy None
rsi ActivelyBuy None None
macd None ActivelyBuy None
stoch None ActivelyBuy None
ma20 Buy Buy None
ma50 ActivelyBuy None None
ma100 Sell Buy None
Candlestick PatternDec. 20, 2024 Bullish Three Inside Up - pattern is a made up of three candlesticks. Big black candlestick appears on the first day in a downtrend. The second day body is engulfed by the body of the first day. A white candlestick on the third day with a higher close than the second day. Considered to be a bullish reversal pattern.
ISIN US0554771032
ceo Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Website https://www.bicara.com
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.